Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-029467
Filing Date
2017-05-02
Accepted
2017-05-02 20:57:09
Documents
2
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4500
2 POA DOCUMENT poa.txt EX-24.4_720798 4020
  Complete submission text file 0001209191-17-029467.txt   10076
Mailing Address 525 RIVERVALE RD RIVERVALE NJ 07675
Business Address
FRIEDHOFF LAWRENCE MD PHD (Reporting) CIK: 0001215890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 17806935

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations